1.
J Crohns Colitis
; 12(1): 124-125, 2018 Jan 05.
Article
in English
| MEDLINE
| ID: mdl-28981641
Subject(s)
Biological Therapy/adverse effects , Hepatitis B virus/physiology , Hepatitis B , Latent Tuberculosis , Mass Screening/methods , Mycobacterium tuberculosis/physiology , Biological Therapy/methods , Hepatitis B/diagnosis , Hepatitis B/epidemiology , Humans , Inflammatory Bowel Diseases/therapy , Latent Tuberculosis/diagnosis , Latent Tuberculosis/epidemiology , Prevalence , Risk Assessment , Virus Activation/drug effects
2.
Arzneimittelforschung
; 21(5): 588-9, 1971 May.
Article
in German
| MEDLINE
| ID: mdl-5109677